December 5, 2018 10:39 AM EST

UK sets up vaccines centre as Brexit looms; Shanghai's Elpiscience bags $35M in Series B

ENDPOINTS

→ Hillhouse Capital has joined Lilly Asia Ventures and CDH Investments in backing Elpiscience, leading a $35 million Series B to boost its cancer …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

UK sets up vaccines centre as Brexit looms; Shanghai's Elpiscience bags $35M in Series B

ENDPOINTS

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Lilly to buy non-opioid pain biotech SiteOne for up to $1B

RFK Jr. ends annual Covid vaccine recommendations for kids, pregnant women

Updated: Patient dies in Rocket gene therapy trial, which is put on clinical hold by FDA

Novartis won bidding war for kidney drug as Regulus' top three execs expect to make over $100M combined

Biogen taps City Therapeutics in RNAi deal worth up to $1B

From weeks to days: how Aizon Intelligent Agents transform pharma validation

UK sets up vac­cines cen­tre as Brex­it looms; Shang­hai's Elpi­science bags $35M in Se­ries B

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

UK sets up vaccines centre as Brexit looms; Shanghai's Elpiscience bags $35M in Series B